Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6151 to 6165 of 7681 results

  1. NICE Board says new method allowing greater weight to be given to severe diseases is working

    At today's meeting (25th September 2024) our board has concluded that the new severity modifier is working as intended.

    News
    Last updated
    25 September 2024

  2. Medicines optimisation: key therapeutic topics – Integrated process statement (PMG13)

    February 2022: we have withdrawn our medicines optimisation: key therapeutic topics.

    We have taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities outlined in our 5-year strategy.

    If you have any queries, please contact nice@nice.org.uk.

  3. Process guide for adoption support resources for health technologies (PMG23)

    This process and methods guide has been withdrawn.

  4. Developing NICE guidelines: how to get involved (PMG22)

    October 2018: This process guide has been updated. The updated version can be found in the tools and resources for developing NICE guidelines: the manual.

  5. Process manual for the endorsement of guidance and quality standard support resources (PMG29)

    The endorsement programme is now closed and no new applications are being accepted. Information about existing endorsed resources, are available on the endorsement webpage. Please email endorsement@nice.org.uk if you have any queries.

  6. Into practice guide (PMG30)

    This guide has been updated and replaced by practical steps to improving the quality of care and services using NICE guidance.

  7. Key therapeutic topics – Medicines management options for local implementation: Interim process statement (PMG7)

    February 2022: we have withdrawn our medicines optimisation: key therapeutic topics.

    We have taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities outlined in our 5-year strategy.

    If you have any queries, please contact nice@nice.org.uk.

  8. SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection (DG7)

    This guidance has been updated and replaced by NICE diagnostics guidance 44.  

    Diagnostics guidance
    Published
    28 November 2012

  9. Ulcerative colitis: management (CG166)

    This guidance has been updated and replaced by NICE guideline NG130.

    Clinical guideline
    Published
    26 June 2013

  10. Myocardial infarction with ST-segment elevation: acute management (CG167)

    This guideline has been updated and replaced by NICE guideline NG185.

    Clinical guideline
    Published
    10 July 2013

  11. Acute kidney injury: prevention, detection and management (CG169)

    This guidance has been updated and replaced by NICE guideline NG148.

    Clinical guideline
    Published
    28 August 2013

  12. Dyspepsia: Management of dyspepsia in adults in primary care (CG17)

    This guidance has been updated and replaced by NICE guideline CG184.

    Clinical guideline
    Published
    25 August 2004

  13. Urinary incontinence in women: management (CG171)

    This guideline has been updated and replaced by NICE guideline NG123.

    Clinical guideline
    Last updated
    5 November 2015

  14. Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease (CG172)

    This guideline has been updated and replaced by NICE guideline NG185.

    Clinical guideline
    Published
    13 November 2013

  15. Intrapartum care for healthy women and babies (CG190)

    This guideline has been updated and replaced by the NICE guideline on intrapartum care (NG235).

    Clinical guideline
    Published
    3 December 2014